Aim To investigate clinical presentation of COVID-19 infection in pregnancy, its course during pregnancy, effects on pregnancy outcomes for both mothers and newborns as well as the potential for vertical transmission. Methods This retrospective observational study included all identifi ed COVID-19-positive pregnant women admitted to the Cantonal Hospital in Zenica at any stage of pregnancy or labour from 30 April 2020 to April 30 2021. Maternity and newborns were followed until discharge from the hospital. Results Twenty-four pregnant women were positive for COVID-19. There were 79.2% asymptomatic cases, 12.5% had mild symptoms, while 8.3% had more severe forms of the disease. The main follow-up morbidities were high BMI 33.3%, anaemia 16.7%, thrombocytopenia 12.5%, hypertensive disorders 4.2% and diabetes 4.2%. The rate of premature births was 33.3%, while 8.3% pregnant women had premature rupture of the amniotic sac. Caesarean section was done for 75% women while 25% delivered vaginally. Previous caesarean section (54.2%) was the most common indication for operative completion of labour. Twentythree (92%) live babies were born, of which 8 (33.3%) were admitted to the neonatal intensive care unit. Two (8%) intrauterine foetal deaths were recorded that occurred before admission to our hospital. Two infants (8.7%) had a positive PCR test for COVID-19. Conclusion COVID-19 viral disease in pregnancy is usually presented as an asymptomatic or mild disease. It is associated with high rates of preterm birth, admission of newborns to the intensive care unit and intrauterine foetal death. Vertical transmission is possible but the newborns were asymptomatic.
Zhu N, Zhang D, Li W, Yang X, Song B, Zhao J, et al. A novel coronavirus from patients with pneumonia in China. N Engl J Med. 2019. p. 727–33.
2.
Rasmussen S, Smulian J, Lednicky J, Wen T, Jamieson D. Coronavirus Disease 2019 (CO-VID-19) and pregnancy: what obstetricians need to know. Am J Obstet Gynecol. 2020. p. 415–26.
3.
A report about health, Bosnia and Herzegovina Situation. 18AD.
4.
Alfaraj S, Al-Tawfiq J, Memish Z. Middle East respiratory syndrome coronavirus (MERS-CoV) infection during pregnancy: report of two cases & review of the literature. J Microbiol Immunol Infect. 2019. p. 501–3.
5.
Mascio D, Khalil D, Saccone A, Rizzo G, Buca G, Liberati D, et al. Outcome of coronavirus spectrum infections (SARS, MERS, COVID-19) during pregnancy: a systematic review and metaanalysis. Am J Obstet Gynecol MFM. 2020. p. 100–7.
6.
Collin J, Byström E, Carnahan A, Ahrne M. Public Health Agency of Sweden’s Brief Report: pregnant and postpartum women with severe acute respiratory syndrome coronavirus 2 infection in intensive care in Sweden. Acta Obstet Gynecol Scand. 2020. p. 819–22.
7.
Specimen Collection, Packaging and Transport Guidelines for 2019 Novel Coronavirus. 20AD.
8.
Nayak A, Kapote D, Fonseca M, Chavan N, Mayekar R, Sarmalkar M, et al. Impact of the coronavirus infection in pregnancy: a preliminary study of 141 patients. J Obstet Gynaecol India. 2020. p. 256–61.
9.
Dória M, Peixinho C, Laranjo M, Varejão M, Silva A, P. Covid-19 during pregnancy: a case seriesfrom an universally tested population from the north of Portugal. Eur J Obstet Gynecol Reprod Biol. 2020. p. 261–2.
10.
Chen H, Guo J, Wang C, Luo F, Yu X, Zhang W, et al. Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records. Lancet. 2020. p. 809–15.
11.
Karimi-Zarchi M, Neamatzadeh H, Dastgheib S, Abbasi H, Mirjalili S, Behforouz A, et al. Vertical transmission of coronavirus disease 19 (COVID-19) from infected pregnant mothers to neonates: a review. Fetal Pediatr Pathol. 2020. p. 246–50.
12.
Khan S, Peng L, Siddique R, Nabi G, Nawsherwan, Xue M, et al. Impact of COVID-19 infection on pregnancy outcomes and the risk of maternalto-neonatal intrapartum transmission of COVID-19 during natural birth. Infect Control Hosp Epidemiol. 2020. p. 748–50.
13.
Zaigham M, Andersson O. Maternal and perinatal outcomes with COVID-19: a systematic review of 108 pregnancies. Acta Obstet Gynecol Scand. 2020. p. 823–9.
14.
Liu H, Wang L, Zhao S, Kwak-Kim J, Mor G, Liao A. Why are pregnant women susceptible to COVID-19? An immunological viewpoint. J Reprod Immunol. 2020. p. 103–22.
15.
Loeffelholz M, Tang YW. Laboratory diagnosis of emerging human coronavirus infections -the state of the art. Emerg Microbes Infect. 2020. p. 747–56.
16.
Elshafeey F, Magdi R, Hindi N, Elshebiny M, Farrag N, Mahdy S, et al. A systematic scoping review of COVID-19 during pregnancy and childbirth. Int J Gynaecol Obstet. 2020. p. 47–52.
17.
Zaigham M, Andersson O. Maternal and perinatal outcomes with COVID-19: a systematic review of 108 pregnancies. Acta Obstet Gynecol Scand. 2020. p. 823–9.
18.
Allotey J, Stallings E, Bonet M, Yap M, Chatterjee S, Kew T, et al. Clinical manifestations, risk factors, and maternal and perinatal outcomes of coronavirus disease 2019 in pregnancy: living systematic review and metaanalysis. BMJ. 2020. p. 3320.
19.
Vale A, Fernandes A, Guzen F, Pinheiro F, De Azevedo E, Cobucci R. Susceptibility to COVID-19 in pregnancy, labor, and postpartum period: immune system, vertical transmission, and breastfeeding. Front Glob Womens Health. 2021. p. 602572.
20.
Kayem G, Lecarpentier E, Deruelle P, Bretelle F, Azria E, Blanc J, et al. A snapshot of the Covid-19 pandemic among pregnant women in France. J Gynecol Obstet Hum Reprod. 2020. p. 101826.
21.
Zambrano L, Ellington S, Strid P, Galang R, Oduyebo T, Tong V, et al. CDC COVID-19 Response Pregnancy and Infant Linked Outcomes Team. Update: characteristics of symptomatic women of reproductive age with laboratory-confirmed SARS-CoV-2 infection by pregnancy status-United States. MMWR Morb Mortal Wkly Rep. p. 1641–7.
22.
Lokken E, Walker C, Delaney S, Kachikis A, Kretzer N, Erickson A, et al. Clinical characteristics of 46 pregnant women with a SARS-CoV-2 infection in Washington State. Am J Obstet Gynecol. 2020. p. 911-e911.
23.
Savasi V, Parisi F, Patanè L, Ferrazzi E, Frigerio L, Pellegrino A, et al. Clinical findings and disease severity in hospitalized pregnant women with coronavirus disease 2019 (COVID-19). Obstet Gynecol. 2020. p. 252–8.
24.
Wang Q, Wu H. T Cells in adipose tissue: critical players in immunometabolism. Front Immunol. 2018. p. 2509.
25.
Li Y, Zhou W, Yang L, You R. Physiological and pathological regulation of ACE2, the SARS-CoV-2 receptor. Pharmacol Res. 2020. p. 104833.
26.
Mullins E, Evans D, Viner R, ’brien O, P, Morris. Coronavirus in pregnancy and delivery: rapid review. Ultrasound Obstet Gynecol. 2020. p. 586–92.
27.
Browne P, Linfert J, Perez-Jorge E. Successful treatment of preterm labor in association with acute COVID-19 infection. Am J Perinatol. 2020. p. 866–8.
28.
Shanes E, Mithal L, Otero S, Azad H, Miller E, Goldstein J. Placental pathology in CO-VID-19. Am J Clin Pathol. 2020. p. 23–32.
29.
Madinger N, Greenspoon J, Ellrodt A. Pneumonia during pregnancy: has modern technology improved maternal and fetal outcome? Am J Obstet Gynecol. 1989. p. 657–62.
30.
Oscar M, Pilar P, Marta M. The association between SARS-CoV-2 infection and preterm delivery: a prospective study with a multivariable analysis. BMC Pregnancy Childbirth. 2021. p. 273.
31.
Dong L, Tian J, He S, Zhu C, Wang J, Liu C, et al. Possible vertical transmission of SARS-CoV-2 from an infected mother to her newborn. JAMA. 2020. p. 1846–8.
32.
Zeng H, Xu C, Fan J, Tang Y, Deng Q, Zhang W, et al. Antibodies in infants born to mothers with COVID-19 pneumonia. JAMA. 2020. p. 1848–9.
33.
Hosier H, Farhadian S, Morotti R, Deshmukh U, Lu-Culligan A, Campbell K, et al. SARS-CoV-2 infection of the placenta. J Clin Invest. 2020. p. 4947–53.
34.
Walker K, ’donoghue O, Grace K, Dorling N, Comeau J, Li J, et al. Maternal transmission of SARS-COV-2 to the neonate, and possible routes for such transmission: a systematic review and critical analysis. BJOG. 2020. p. 1324–36.
35.
Lubbe W, Botha E, Niela-Vilen H, Reimers P. Breastfeeding during the COVID-19 pandemic -a literature review for clinical practice. Int Breastfeed J. 2020. p. 82.
The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.
,
